N/A N=100 Screen to Save: A Colorectal Cancer Educational Intervention
Colorectal Cancer
Primary: Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening — 1 score on a scale — p=0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=36 Effect of Ileal Bile Acid Transporter Inhibitor in Functional Constipation
Functional Constipation
Primary: Colonic Transit at 24 Hours — 2.68; 3.12; 1.93 units on a scale — p=0.059
Phase 3 N=80 Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty
Total Hip Arthroplasty
Primary: Pain Scores Using Visual Analog Scale (VAS) Scores — 2.34; 3.33 units on a scale
Phase 4 N=90 Antiarrhythmic Effects of Spironolactone in Patients With ICDs
Ventricular Arrhythmias
Primary: Time to First Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy — 8.8; 12.3 months — p=0.71
Phase 3 N=120 Efficacy and Safety Evaluation in Recurrent Wheezing Attacks
Bronchospasm; Bronchiolitis · Bronchospasm; Bronchitis
Primary: Number of Recurrent Bronchospasm (Wheezing Attacks) — 299; 176 events
N/A N=36 Treatment for Nicotine Addiction in Women
Nicotine Dependence
Primary: Withdrawal Symptoms (MNWS Score) — 13.33; 9.40; 11.95; 13.29 score on a scale — p=0.18
Phase 2 N=160 Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Primary: Change From Baseline in FVC (Percent of Predicted FVC Value [% Predicted]) to Week 48 — 74.51; 72.82; -2.71; -7.20 % predicted FVC — p== 0.0331
Phase 3 N=360 Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Cataract · Inflammation · Surgery
Primary: Percentage of Participants With Complete Resolution of Anterior Chamber (AC) Cells — 38; 13 Participants
Phase 2 N=64 Study of T-PRED(TM) Compared to Pred Forte(R)
Cataract
Primary: Mean Aqueous Humor Prednisolone Acetate Concentration — 102.5; 127.5 ng/mL
N/A N=59 Information Visualizations to Facilitate HIV-related Patient-provider Communication (Info Viz: HIV)
Health Communication
Primary: Association Between Mean CD4 Count at Baseline and 3-month Visit — 385.86; 373.69 cells/mm^3 — p=0.859
Phase 3 N=374 Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
HIV Associated Diarrhea
Primary: Primary Efficacy Outcome is Count of Participants With Two or Less Watery Bowel Movements Per Week During at Least Two Weeks of the Treatment Phase of the Optimal Dose…
Phase 3 N=514 Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
Inflammation · Pain · Cataract
Primary: Percentage of Participants With Complete Resolution of Anterior Chamber (AC) Cells — 16; 46; 49 Participants
N/A N=197 Evaluation of Cellphone Based Otoscopy in Pediatric Patients
Ear Infection · Pediatric Disease · Acute Otitis Media
Primary: Concordance of Trainee and Supervisor Utilizing the OMgrade Scale as Assessed by the Concordance-statistic — 0.64; 0.75 concordance-statistic
Phase 2 N=56 A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma
Waldenstrom's Macroglobulinemia · Multiple Myeloma
Primary: Percentage of Participants With Complete Response (CR), Partial Response (PR) and Minimal Response (MR) or Minor Response (MinR): (Response Rate) — 7.1; 38.1 percentage…
N/A N=49 Vaginally Assisted Laparoscopic Hysteropexy Versus Vaginal Hysterectomy
Pelvic Organ Prolapse
Primary: Number of Participants With Recurrence of Pelvic Organ Prolapse — 0; 0 Participants